MAYRA CASILLAS: Open Payments
NPI 1851174494 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 37 payments from 16 companies in 2025. Trend: 2023 $372 · 2024 $1,252 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $295 |
| Novo Nordisk Inc | 5 | $177 |
| Otsuka America Pharmaceutical, Inc. | 3 | $172 |
| Globus Medical, Inc. | 1 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Merck Sharp & Dohme LLC | 2 | $68 |
| Amgen Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: REXULTI, Ozempic, BREZTRI, AIRSUPRA, Senza, JARDIANCE, VERQUVO, REPATHA.
Industry payments across CA — which companies pay providers there.
